Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Housem Bouchiba"'
Autor:
Christophe Rogier, Serge-Brice Assi, Housem Bouchiba, Marie-Claire Henry, Bruno Pradines, Eric Garnotel, Thierry Fusai, Mohamed Ali Kamil, Odile Puijalon, Patrick Durand, Eric Adehossi, Hervé Bogreau, François Renaud, Philippe Parola, Boubacar Wade
Publikováno v:
Europe PubMed Central
The genetic variability and population structure of Plasmodium falciparum are key factors in malaria control strategies. Studies have suggested no P. falciparum population structure although linkage disequilibrium was observed in some African areas.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4af2296c4220fcccc8a4c8ca8e2ba615
https://doi.org/10.4269/ajtmh.2006.74.953
https://doi.org/10.4269/ajtmh.2006.74.953
Autor:
Hervé Bogreau, Joel Mosnier, Eve Orlandi-Pradines, Eric Baret, Kristell Penhoat, Marie-Claire Henry, Thierry Fusai, C. Durand, Housem Bouchiba, Christophe Rogier, Bruno Pradines
Publikováno v:
Annales Pharmaceutiques Françaises. 63:284-294
Resume Le developpement considerable et rapide des resistances aux medicaments utilises contre le paludisme est une des motivations essentielles a la recherche de nouvelles molecules. L’utilisation de complexes organometalliques, seuls ou en associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::319360e5d7f082733561c02f6c353226
https://doi.org/10.1016/s0003-4509(05)82293-x
https://doi.org/10.1016/s0003-4509(05)82293-x
Autor:
Hervé Bogreau, Housem Bouchiba, Christophe Rogier, Marine Gil, Bruno Pradines, Eric Baret, Rémy Amalvict, Sébastien Briolant
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 2012, 56 (5), pp.2750-2. ⟨10.1128/AAC.05618-11⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2012, 56 (5), pp.2750-2. ⟨10.1128/AAC.05618-11⟩
Antimicrobial Agents and Chemotherapy, 2012, 56 (5), pp.2750-2. ⟨10.1128/AAC.05618-11⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2012, 56 (5), pp.2750-2. ⟨10.1128/AAC.05618-11⟩
Screening for in vitro susceptibility to pyrimethamine and sequencing of the pfmdr2 and pfdhfr genes were performed in 140 Plasmodium falciparum isolates. The risk of in vitro resistance to pyrimethamine was analyzed with a logistic regression model.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89ead8c11b9bffbd31448345a95259a4
https://hal-riip.archives-ouvertes.fr/pasteur-00835590/file/22314533BriolantAntimicrobAgentsChemother2012_56_5_2750-2.pdf
https://hal-riip.archives-ouvertes.fr/pasteur-00835590/file/22314533BriolantAntimicrobAgentsChemother2012_56_5_2750-2.pdf
Autor:
Housem Bouchiba, Nathalie Wurtz, Vincent Pommier de Santi, Maryse Martelloni, Marc Desbordes, Bruno Pradines, Nicolas Benoit, Georges Richa, Nicolas Taudon, Sébastien Briolant, Adeline Marin-Jauffre, Aurélie Pascual
Publikováno v:
Malaria Journal, Vol 11, Iss 1, p 146 (2012)
Malaria Journal
Malaria Journal
The increased spread of drug-resistant malaria highlights the need for alternative drugs for treatment and chemoprophylaxis. The combination of atovaquone‐proguanil (Malarone®) has shown high efficacy against Plasmodium falciparum with only mild s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d35be87351acaa8c6f56d95e634aa6cf
http://www.malariajournal.com/content/11/1/146
http://www.malariajournal.com/content/11/1/146
Autor:
Hervé Bogreau, Housem Bouchiba, Ali Ould Mohamed Salem Boukhary, Mohamed Salem Ould Ahmedou Salem, Nathalie Wurtz, Christophe Rogier, Khadijetou Mint Lekweiry, Jamal Eddine Hafid, Sébastien Briolant, Jean-François Trape, Leonardo K. Basco, Tiphaine Gaillard, Bruno Pradines
Objectives: Plasmodium falciparum and Plasmodium vivax occur in Mauritania. Drug-resistant P. falciparum has been reported, but the drug-resistance status of P. vivax is unknown. The aims of the present study were to determine the prevalence of mutan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5111aed09c6c23b9693ebc8c0b094f92
http://www.documentation.ird.fr/hor/fdi:010069110
http://www.documentation.ird.fr/hor/fdi:010069110
Autor:
Hervé Bogreau, Bruno Pradines, Philippe Kraemer, Fabrice Simon, Hélène Savini, Housem Bouchiba, Daniel Parzy, Eric Garnotel, Christophe Rogier, Lionel Bertaux
Atovaquone-proguanil (Malarone; GlaxoSmithKline) is now commonly used for the treatment and prophylaxis of falciparum malaria in France. We report here a treatment failure of atovaquone-proguanil in a patient who was infected during a 33-day visit wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39eefd90f2f07f0ac8c3c15729b9183
https://europepmc.org/articles/PMC2415798/
https://europepmc.org/articles/PMC2415798/